Antibiotic resistance isn’t just a pharmaceutical problem

  20 October 2022

Researchers gathered at McMaster University on Friday to discuss the biological, societal and political contributions to antibiotic resistant bacteria, a concern the McMaster University’s Global Nexus has dubbed “ the next pandemic .”

Anti-microbial resistance (AMR) occurs when infection-causing pathogens — like bacteria, viruses, fungi and parasites — develop immunity or defences against medications that would otherwise kill them. This resistance allows the infection to spread at a rapid rate, as the medications clear out any competition from nonresistant strains. This phenomenon has led to the rise of “superbugs,” like MRSA (Methicillin-resistant Staphylococcus aureus).

Further reading: Healthing
Author(s): Emma Jones
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!